Ireland - English - HPRA (Health Products Regulatory Authority)

zoetis ireland limited - live canine parvovirus strain nl-35-d - solution for injection - unknown - canine parvovirus vaccine - canine - immunological - live vaccine

Ireland - English - HPRA (Health Products Regulatory Authority)

zoetis ireland limited - live canine parvovirus strain nl-35-d, leptospira canicola inactivated, leptospira icterohaemorrhagiae inactivated - solution for injection - %v/v - live canine parvovirus vaccine + inactivated leptospira vaccine - canine - immunological - mixed vaccine (live and inactivated)

Ireland - English - HPRA (Health Products Regulatory Authority)

virbac s.a. - canine distemper virus (lederle strain), canine adenovirus type 2 (manhattan strain), canine parvovirus (cpv 780916 strain), canine parainfluenza (manhattan strain), buffered isotonic solution, l.canicola, l.icterohaemorrhagiae - suspension for injection - unknown - live canine distemper virus vaccine + live canine adenovirus vaccine + live canine parainfluenza vi - canine - immunological - live vaccine

Ireland - English - HPRA (Health Products Regulatory Authority)

merial animal health limited - attenuated canine distemper virus, strain ba5, attenuated canine adenovirus type 2, strain dk13, attenuated canine parvovirus, strain cgf - lyophilisate and solvent for suspension for injection - unknown - canine distemper virus vaccine + canine adenovirus vaccine + canine parvovirus vaccine - canine - immunological - live vaccine

Ireland - English - HPRA (Health Products Regulatory Authority)

merial animal health limited - canine distemper virus, live, canine adenovirus type 2, live, canine parvovirus, live, canine parainfluenza virus, live - lyophilisate and solvent for solution for injection - unknown - canine distemper virus vaccine + canine adenovirus vaccine + canine parvovirus vaccine + canine para - canine - immunological - live vaccine

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - canine parainfluenza type-2 virus, strain cpiv-2 bio 15 (live attenuated) - immunologicals for canidae, live viral vaccines - dogs - active immunisation of dogs from six weeks of age to prevent clinical signs (nasal and ocular discharge) and reduce viral excretion caused by canine parainfluenza virus.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa. - canine parainfluenza type 2 virus, strain cpiv-2 bio 15 (live attenuated), leptospira interrogans serogroup australis serovar bratislava, strain mslb 1088, l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089, l. interrogans serogroup canicola serovar canicola, strain mslb 1090 and l. kirschneri serogroup grippotyphosa serovar grippotyphosa, strain mslb 1091 (all inactivated) - immunologicals for canidae, live viral and inactivated bacterial vaccines - dogs - active immunisation of dogs from six weeks of age. - to prevent clinical signs and reduce viral excretion caused by canine parainfluenza virus, - to prevent clinical signs, infection and urinary excretion caused by leptospira serovars bratislava, canicola, grippotyphosa and icterohaemorrhagiae. onset of immunity: immunity has been demonstrated from 3 weeks after completion of the primary course for cpiv and from 4 weeks after completion of the primary course for leptospira components. duration of immunity: at least one year following the primary vaccination course for all components of versican plus pi/l4.

European Union - English - EMA (European Medicines Agency)

zoetis belgium s.a. - canine parainfluenza virus, leptospira and rabies virus. - immunologicals for canidae, live and inactivated viral and bacterial vaccines - dogs - active immunization of dogs from six weeks of age to prevent clinical signs and reduce viral excretion cause by canine parainfluenza virus, to prevent clinical signs, infection and urinary excretion cause by leptospira serovars bratislava, canicola, grippotyphosa and icterohaemorrhagiae and to prevent mortality, clinical signs and infection cause by rabies virus.

Ireland - English - HPRA (Health Products Regulatory Authority)

intervet ireland limited - live attenuated mycoplasma synoviae strain ms1 - lyophilisate for oculonasal suspension/use in drinking water - . - mycoplasma - chickens - immunological - live vaccine

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - measles virus, quantity: 3 tcid50; mumps virus, quantity: 4.3 tcid50; rubella virus, quantity: 3 tcid50; live varicella vaccine, quantity: 3.99 pfu - injection, powder for - excipient ingredients: potassium chloride; hydrolysed gelatin; urea; neomycin; sodium bicarbonate; albumin; sodium chloride; sucrose; monobasic sodium phosphate; dibasic sodium phosphate; phenolsulfonphthalein; monosodium glutamate monohydrate; monobasic potassium phosphate; dibasic potassium phosphate; sorbitol; glucose monohydrate; magnesium sulfate heptahydrate; ferric nitrate nonahydrate; dibasic sodium phosphate dihydrate; sodium pyruvate; folic acid; calcium pantothenate; inositol; choline chloride; nicotinamide; pyridoxine hydrochloride; thiamine hydrochloride; riboflavine; cystine; tyrosine; arginine; glycine; histidine; isoleucine; leucine; lysine; methionine; phenylalanine; threonine; tryptophan; serine; valine; glutamine; calcium chloride dihydrate; water for injections; ascorbic acid; polysorbate 80; adenine sulfate dihydrate; adenosine triphosphate disodium; adenosine phosphate; cholesterol; deoxyribose; glutathione; guanine hydrochloride monohydrate; sodium hypoxanthine; ribose; sodium acetate; thymine; uracil; sodium xanthine; dl-alanine; arginine hydrochloride; dl-aspartic acid; cysteine hydrochloride; cystine dihydrochloride; dl-glutamic acid; histidine hydrochloride; hydroxyproline; dl-leucine; lysine hydrochloride; dl-methionine; dl-phenylalanine; proline; dl-serine; dl-threonine; dl-tryptophan; tyrosine disodium; dl-valine; biotin; ergocalciferol; menadione; nicotinic acid; aminobenzoic acid; pyridoxal hydrochloride; retinol acetate; dl-alpha-tocopheryl phosphate disodium - proquad is indicated for simultaneous immunisation against measles, mumps, rubella and varicella in individuals 12 months through 12 years of age.